NYSE:JRI

Nuveen Real Asset Income and Growth Fund Stock Forecast, Price & News

$15.94
-0.03 (-0.19 %)
(As of 09/17/2021 12:00 AM ET)
Add
Compare
Today's Range
$15.86
$16.06
50-Day Range
$15.39
$16.40
52-Week Range
$11.60
$16.50
Volume57,430 shs
Average Volume90,276 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend Yield0.08%
BetaN/A
30 days | 90 days | 365 days | Advanced Chart
Receive JRI News and Ratings via Email

Sign-up to receive the latest news and ratings for Nuveen Real Asset Income and Growth Fund and its competitors with MarketBeat's FREE daily newsletter.


About Nuveen Real Asset Income and Growth Fund

Nuveen Real Asset Income and Growth Fund is an closed ended balanced mutual fund launched by Nuveen Investments, Inc. The fund is co-managed by Nuveen Fund Advisors LLC and Nuveen Asset Management, LLC. It invests in the public equity markets across the globe. The fund also makes its investments in depository receipts. It invests in stocks of companies operating in real estate sector. For the fixed income portion of its portfolio the fund invest in investment grade quality rated BB+/Ba1 or lower. Nuveen Real Asset Income and Growth Fund was formed on April 25, 2012 and is domiciled in the United States.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

0.77 out of 5 stars

Analyst Opinion: 0.0Community Rank: 3.9Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Nuveen Real Asset Income and Growth Fund (NYSE:JRI) Frequently Asked Questions

What stocks does MarketBeat like better than Nuveen Real Asset Income and Growth Fund?

Wall Street analysts have given Nuveen Real Asset Income and Growth Fund a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Nuveen Real Asset Income and Growth Fund wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Nuveen Real Asset Income and Growth Fund?

Nuveen Real Asset Income and Growth Fund saw a decline in short interest in August. As of August 31st, there was short interest totaling 5,800 shares, a decline of 80.9% from the August 15th total of 30,400 shares. Based on an average trading volume of 73,400 shares, the short-interest ratio is currently 0.1 days.
View Nuveen Real Asset Income and Growth Fund's Short Interest
.

How has Nuveen Real Asset Income and Growth Fund's stock price been impacted by Coronavirus (COVID-19)?

Nuveen Real Asset Income and Growth Fund's stock was trading at $13.93 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, JRI shares have increased by 14.4% and is now trading at $15.94.
View which stocks have been most impacted by COVID-19
.

How often does Nuveen Real Asset Income and Growth Fund pay dividends? What is the dividend yield for Nuveen Real Asset Income and Growth Fund?

Nuveen Real Asset Income and Growth Fund declared a monthly dividend on Wednesday, September 1st. Investors of record on Wednesday, September 15th will be paid a dividend of $0.097 per share on Friday, October 1st. This represents a $1.16 annualized dividend and a dividend yield of 7.30%. The ex-dividend date is Tuesday, September 14th.
View Nuveen Real Asset Income and Growth Fund's dividend history
.

Is Nuveen Real Asset Income and Growth Fund a good dividend stock?

Nuveen Real Asset Income and Growth Fund pays an annual dividend of $1.27 per share and currently has a dividend yield of 0.08%.
View Nuveen Real Asset Income and Growth Fund's dividend history.

Who are Nuveen Real Asset Income and Growth Fund's key executives?

Nuveen Real Asset Income and Growth Fund's management team includes the following people:
  • Mr. John G. Wenker, Portfolio Mang. (Age 70)
  • Mr. Jay L. Rosenberg, Managing Director, Head of Investments for Real Assets and Lead Portfolio Mang.
  • Mr. Tryg T. Sarsland, Portfolio Mang.
  • Ms. Brenda A. Langenfeld C.F.A., CFA, Sr. VP and Portfolio Mang.

Who are some of Nuveen Real Asset Income and Growth Fund's key competitors?

What other stocks do shareholders of Nuveen Real Asset Income and Growth Fund own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Nuveen Real Asset Income and Growth Fund investors own include AT&T (T), International Business Machines (IBM), ONEOK (OKE), Simon Property Group (SPG), Enterprise Products Partners (EPD), Altria Group (MO), Pfizer (PFE), Verizon Communications (VZ), BP (BP) and Exxon Mobil (XOM).

What is Nuveen Real Asset Income and Growth Fund's stock symbol?

Nuveen Real Asset Income and Growth Fund trades on the New York Stock Exchange (NYSE) under the ticker symbol "JRI."

Who are Nuveen Real Asset Income and Growth Fund's major shareholders?

Nuveen Real Asset Income and Growth Fund's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Parametric Portfolio Associates LLC (0.00%), Relative Value Partners Group LLC (0.00%), Advisors Asset Management Inc. (0.00%), Camelot Portfolios LLC (0.00%), Wells Fargo & Company MN (0.00%) and Morgan Stanley (0.00%).
View institutional ownership trends for Nuveen Real Asset Income and Growth Fund
.

Which major investors are selling Nuveen Real Asset Income and Growth Fund stock?

JRI stock was sold by a variety of institutional investors in the last quarter, including Advisors Asset Management Inc., Relative Value Partners Group LLC, Quantedge Capital Pte Ltd, Camelot Portfolios LLC, Sterneck Capital Management LLC, Morgan Stanley, Morgan Stanley, and Mid Atlantic Financial Management Inc. ADV.
View insider buying and selling activity for Nuveen Real Asset Income and Growth Fund
or view top insider-selling stocks.

Which major investors are buying Nuveen Real Asset Income and Growth Fund stock?

JRI stock was bought by a variety of institutional investors in the last quarter, including Parametric Portfolio Associates LLC, Steward Partners Investment Advisory LLC, Advisor Resource Council, Private Advisor Group LLC, LPL Financial LLC, Advisor Group Holdings Inc., Goldman Sachs Group Inc., and RSM US Wealth Management LLC.
View insider buying and selling activity for Nuveen Real Asset Income and Growth Fund
or or view top insider-buying stocks.

How do I buy shares of Nuveen Real Asset Income and Growth Fund?

Shares of JRI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Nuveen Real Asset Income and Growth Fund's stock price today?

One share of JRI stock can currently be purchased for approximately $15.94.

What is Nuveen Real Asset Income and Growth Fund's official website?

The official website for Nuveen Real Asset Income and Growth Fund is www.nuveen.com.

Where are Nuveen Real Asset Income and Growth Fund's headquarters?

Nuveen Real Asset Income and Growth Fund is headquartered at 155 Federal St Ste 700, Boston, Massachusetts 02110-1727.


This page was last updated on 9/17/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.